Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indra Neil Guha

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
British Medical Bulletin|October 25, 2014
Non-invasive monitoring of liver fibrosisRobert Scott, Indra Neil Guha
BMJ (Clinical Research Ed.)|December 17, 2013
Were James Bond's drinks shaken because of alcohol induced tremor?Graham Johnson, Indra Neil Guha, Patrick Davies
Journal of Hepatology|January 24, 2006
Performance of serum marker panels for liver fibrosis in chronic hepatitis CJulie Parkes, Indra Neil Guha, Paul Roderick, et al.
Open Heart|September 1, 2015
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessmentStephen F Weng, Joe Kai, Indra Neil Guha, et al.
Hepatology (Baltimore, Md.)|July 5, 2011
Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?Indra Neil Guha, Robert P Myers, Keyur Patel, et al.
The International Journal of Biochemistry & Cell Biology|November 18, 2006
Resolving fibrosis in the diseased liver: translating the scientific promise to the clinicAjay K Muddu, Indra Neil Guha, Ahmed M Elsharkawy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2024
Interpreting elevated liver blood test results through a genetic lens: A genome-wide association studyHamish Innes, Stephan Buch, Timothy J Kendall, et al.
Comparative Hepatology|January 1, 2013
Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver diseaseJulie Parkes, Indra Neil Guha, Scott Harris, et al.
Journal of Hepatology|March 10, 2022
Performance of routine risk scores for predicting cirrhosis-related morbidity in the communityHamish Innes, Joanne R Morling, Stephan Buch, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic reviewRebecca Harris, David J Harman, Timothy R Card, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
British Medical Bulletin|October 25, 2014
Non-invasive monitoring of liver fibrosisRobert Scott, Indra Neil Guha
BMJ (Clinical Research Ed.)|December 17, 2013
Were James Bond's drinks shaken because of alcohol induced tremor?Graham Johnson, Indra Neil Guha, Patrick Davies
Journal of Hepatology|January 24, 2006
Performance of serum marker panels for liver fibrosis in chronic hepatitis CJulie Parkes, Indra Neil Guha, Paul Roderick, et al.
Open Heart|September 1, 2015
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessmentStephen F Weng, Joe Kai, Indra Neil Guha, et al.
Hepatology (Baltimore, Md.)|July 5, 2011
Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?Indra Neil Guha, Robert P Myers, Keyur Patel, et al.
The International Journal of Biochemistry & Cell Biology|November 18, 2006
Resolving fibrosis in the diseased liver: translating the scientific promise to the clinicAjay K Muddu, Indra Neil Guha, Ahmed M Elsharkawy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2024
Interpreting elevated liver blood test results through a genetic lens: A genome-wide association studyHamish Innes, Stephan Buch, Timothy J Kendall, et al.
Comparative Hepatology|January 1, 2013
Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver diseaseJulie Parkes, Indra Neil Guha, Scott Harris, et al.
Journal of Hepatology|March 10, 2022
Performance of routine risk scores for predicting cirrhosis-related morbidity in the communityHamish Innes, Joanne R Morling, Stephan Buch, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic reviewRebecca Harris, David J Harman, Timothy R Card, et al.
Pageof 6